Steve Hurly, Lava CEO

La­va breaks pro­longed si­lence with an $83M Se­ries C and two I/O pro­grams set for the clin­ic

La­va de­buted in May of 2018 with $18.9 mil­lion, a plat­form built around some­thing called gam­ma delta cells and a plan, ap­par­ent­ly, of say­ing …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.